Geographical reach in clinical research operations

Wemedoo supports clinical research across geographies, enabling studies to run globally without location-based limitations. Our operating model is built around active study execution, global collaboration, and unified systems that ensure consistency across all regions.

Talk to our team

25+ Countries where studies are supported

600+ Clinical sites connected through our systems

60+ Clinical trials supported globally

10,000+ Study participants

24/7 Operational coverage across time zones

Global Reach

Global clinical research performance & reach

Wemedoo combines global study coverage with measurable performance improvements across clinical trial execution.

Global reach includes:

25+ countries where studies are supported

600+ clinical sites connected through our systems

80+ clinical trials supported globally

24/7 operational coverage across time zones

Active in 25+ countries across Europe, Americas, Asia-Pacific and beyond

Our Platform

Unifying your clinical trial
data management

oomnia, our clinical research information system unifies clinical research data, and turns fragmented data into a continuous, structured flow. It brings together eight essential tools in one unified system.

EDC RTSM eTMF CTMS eSource ePRO eCOA eConsent

0 %

Faster Trial Setup Client trial set up with 5000 questions compared to time needed by one of the biggest global CROs for the same trial in a different geography

Real-Time Trial Oversight

Cost reduction

Faster

Accelerate every step of trial lifecycle

80–90% faster protocol amendments
Up to 90% faster LPLV (Last patient, last visit) to database lock

Smarter

Data that updates automatically, insights delivered in real time

100% data standardization

Cost-efficient

Achieve more while spending less

>50% increase in operational efficiency
Up to 80% reduction in manual work

Designed for measurable impact

Performance metrics are based on internal benchmark analyses, client feedback, and case study data, including comparative trial setup timelines, automation impact (e.g., randomization, Study Data Tabulation Model (SDTM) mapping), and accelerated database lock in a complex Phase III study. Results may vary depending on study design and implementation scope.

Frequently asked questions

How does Wemedoo support global trials?

Wemedoo supports global trials through a unified platform that enables centralized data oversight, standardized workflows, and seamless collaboration across regions. With a strong global presence, Wemedoo has contributed to 80+ clinical trials across 200+ sites in 25 countries, supported by a team of 50+ interdisciplinary experts. This enables sponsors and CROs to efficiently manage multi-country studies within a single, connected environment. This is supported by centralized data management and real-time trial visibility, standardized processes across countries, sites, and teams, seamless collaboration between sponsors, CROs, and research sites, and 24/7 operational support ensuring continuous trial execution across time zones. By combining global experience with a unified system, Wemedoo ensures consistent trial delivery, improved coordination, and full control over clinical operations worldwide.

What regions are covered?

Wemedoo supports global operations, enabling clinical trial execution in any market worldwide.

Why is 24/7 readiness important?

Wemedoo provides 24-hour support and system readiness, ensuring that urgent issues, including time-sensitive fixes and integrations, are addressed without delay, always keeping studies compliant and operational.